Pete Joyce, Grey Wolf Therapeutics

"You spend 95% of your time in R&D dealing with things not working or your idea not being correct. It's critical to be prepared and plan ahead for both success and failure." Pete Joyce is the CEO of Grey Wolf Therapeutics, an immuno-oncology company taking a novel, tumour-targeting approach to treating cancer. Pete joined us on Careers in Discovery to talk about his career, the virtual Biotech model, the importance of values and culture and how a stint in Regulatory Affairs influenced his perspective on his research. Enjoy!